Abstract:Objective: The Cardiovascular Outcomes in Renal Atherosclerotic Lesions Trial found no benefit of renal artery stenting (RAS) over medical therapy, although it was underpowered to detect a benefit among patients with chronic kidney disease (CKD). A post hoc analysis demonstrated improved event-free survival after RAS for patients whose renal function improved by 20% or more. A significant obstacle to achieving this benefit is the inability to predict which patients' renal function will improve from RAS. The objectives of the current study were to identify predictors of renal function response to RAS. Methods: The Veteran Affairs Corporate Data Warehouse was queried for patients who underwent RAS between 2000 and 2021. The primary outcome was improvement in renal function (estimated glomerular filtration rate [eGFR]) after stenting. Patients were categorized as responders if the eGFR at 30 days or greater after stenting increased by 20% or more compared with before stenting. All others were nonresponders. Results: The study cohort included 695 patients with a median follow-up of 7.1 years (interquartile range, 3.7-11.6 years). Based on postoperative change in eGFR, 202 stented patients (29.1%) were responders, and the remainder (n = 493 [70.9%]) were nonresponders. Before RAS, responders had a significantly higher mean serum creatinine, lower mean eGFR, and higher rate of decline of preoperative GFR in the months before stenting. After stenting, responders had a 26.1% increase in eGFR, compared with before stenting (P < .0001), which remained stable during follow-up. In contrast, nonresponders had a progressive 5.5% decrease in eGFR after stenting. Logistic regression analysis identified three predictors of renal function response to stenting: (1) diabetes (odds ratio [OR], 0.64; 95% confidence interval [CI], 0.44-0.91; P = .013), (2) CKD stages 3b or 4 (OR, 1.80; 95% CI, 1.26-2.57; P = .001), and (3) rate of decline in preoperative eGFR per week before stenting (OR, 1.21; 95% CI, 1.05-1.39; P = .008). CKD stages 3b and 4 and the rate of decline in preoperative eGFR are positive predictors of renal function response to stenting, whereas diabetes is a negative predictor. Conclusions: Based on our data, patients in CKD stages 3b and 4 (eGFR 15-44 mL/min/1.73 m2) are the only subgroups with a significant probability of improved renal function after RAS. The rate of decline of preoperative eGFR over the months before stenting is a powerful discriminator of patients who are most likely to benefit from RAS. Specifically, patients with a more rapid decrease in eGFR before stenting have a significantly greater probability of improved renal function with RAS. In contrast, diabetes is a negative predictor of improved renal function, so interventionalists should be circumspect about RAS in diabetic patients.

Prediction of Split Renal Function Improvement after Renal Artery Stenting by Blood Oxygen Level–Dependent Magnetic Resonance Imaging

Diagnosis and Prediction of Early Acute Renal Transplant Rejection with Blood Oxygen Level Dependent Magnetic Resonance Imaging

Short-Term Outcomes Using a Drug-Coated Balloon for Transplant Renal Artery Stenosis

Functional Evaluation of Intracranial Atherosclerotic Stenosis by Pressure Ratio Measurements

A preliminary study of renal function for renal artery stenosis using multiparametric magnetic resonance imaging

The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis.

Patterns of cortical oxygenation may predict the response to stenting in subjects with renal artery stenosis: A radiomics-based model

Predicting renal function response to renal artery stenting

Magnetic Resonance Imaging in Atherosclerotic Renal Artery Stenosis: the Update and Future Directions from Interventional Perspective

Detection of renal allograft rejection using blood oxygen level-dependent and diffusion weighted magnetic resonance imaging: a retrospective study.

Absolute Stenosis Measures of Renal Artery Independently Influence Kidney Perfusion in Contrast-Enhanced Multidetector Computed Tomography

Renal perfusion improvement in the perioperative period after unilateral endovascular revascularization in patients with atherosclerotic renal artery stenosis

Functional evaluation of transplanted kidneys in normal function and acute rejection using BOLD MR imaging.

The Efficacy of Endovascular Interventional in Severe Stenosis of Bilateral Renal Stenosis

Renal Dynamic Imaging for the Treatment Assessment of Renal Artery Angioplasty and Stenting in Patients with Atherosclerotic Renal Artery Stenosis

Hemodynamic Analysis of Renal Artery Stenosis Using Computational Fluid Dynamics Technology Based on Unenhanced Steady-State Free Precession Magnetic Resonance Angiography: Preliminary Results.

Perfusion and oxygenation in allografts with transplant renal artery stenosis: Evaluation with functional magnetic resonance imaging

Functional evaluation of acute ischemia / reperfusion injury using bold and arterial spin labeling mri

[Magnetic Resonance Imaging of Mesenchymal Stem Cells Transplanted Intravascularly in Treatment of Acute Renal Failure:In Vivo Experiment with Rats].

A new noninvasive and patient-specific hemodynamic index for the severity of renal stenosis and outcome of interventional treatment

Determinant role of renal artery stenting in recovery from acute worsening of atherosclerotic renal failure